Trial for cancer drug rash relief withdrawn before starting
NCT ID NCT04731259
Summary
This study aimed to test the safety of an experimental cream called ATR-04 for reducing the severity of a painful, acne-like facial rash that is a common side effect of certain cancer drugs. It planned to enroll about 60 adult cancer patients who were starting these specific medications. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMAL GROWTH FACTOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.